FILTER

FILTERED INTERVIEW RESULTS

Federico De Simone

DIRECTOR, DE SIMONE GROUP
De Simone undertakes engineering and construction for the mining sector across West Africa.

Bernard Kaninda

AFRICA REGIONAL DIRECTOR, MAXAM
Maxam offers sophisticated blasting technology that considers all aspects of the conditions, as well as the environment that surrounds them in West Africa.

Hicham Aziz

COUNTRY MANAGER, SENEGAL, SAUDEQUIP (JA DELMAS)
Saudequip is developing its Caterpillar dealership in parallel with Senegal’s fast-growing mining industry.

Douglas MacQuarrie & Bashir Ahmed

PRESIDENT AND CEO & VICE PRESIDENT PRODUCTION AND DEVELOPMENT, ASANTE GOLD
Asante Gold is benefiting from strong gold prices to bring its Kubi mine in Ghana to production.

Louis Watum

PRESIDENT OF THE CHAMBER OF MINES, DRC
The Chamber of Mines of the DRC explains the conditions relating to the mining industry there.

Stephen Smithyman

CEO, KANU EQUIPMENT
Kanu Equipment comments on the challenges and opportunities in Africa for a mining and construction dealership.

Luke Alexander

PRESIDENT, CEO AND DIRECTOR, NEWCORE GOLD LTD.
Newcore Gold enthuses about the prospects of its major drilling campaign at its Enchi gold project in Ghana.

Liam Morrissey

CEO, MS RISK
MS Risk speaks of the danger that the war in the Sahel represents to mines and businesses.

Simon Meadows Smith

MANAGING DIRECTOR, SEMS EXPLORATION SERVICES
SEMS Exploration is a consultancy and exploration services company in West Africa. Geologist and Managing Director, Simon Meadows Smith, walks us through the trends he observes in the region.

John Gladston

GOVERNMENT AFFAIRS MANAGER, FIRST QUANTUM MINERALS LIMITED (FIRST QUANTUM)
First Quantum comments on the performance of its Zambian copper assets during 2020.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS